C000104936 Performance — Health Sciences Fund, Class NAV
Data updated: 2025-04-28
C000104936 returned −0.24% over one year to Feb 2025. Annualised returns are +3.71% over 3 years and +7.97% over 5 years. The fund beat its Health Care Equity category average: $100 invested three years ago grew to $112, against $107 for the category, and to $100 over one year, against $99. Volatility over the past three years was 15.29% a year. In the 12 months to Feb 2025 the fund lost a net $135.4M, and assets reached $94.53M.
C000104936 Growth of $100
What $100 invested in Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | C000104936 | Category average |
|---|---|---|
| 1 year (Mar 2024 – Feb 2025) | $100 | $99 |
| 3 years (Mar 2022 – Feb 2025) | $112 | $107 |
| 5 years (Mar 2020 – Feb 2025) | $147 | $136 |
| Since data start (Sep 2019 – Feb 2025) | $156 | $146 |
C000104936 Trailing Returns
Total returns to Feb 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −0.24% |
| 3 years (annualised) | +3.71% |
| 5 years (annualised) | +7.97% |
C000104936 Annual Returns
Calendar-year total returns of Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Feb) | +4.40% |
| 2024 | +1.86% |
| 2023 | +4.23% |
| 2022 | −12.94% |
| 2021 | +11.50% |
| 2020 | +26.56% |
| 2019 (Sep–Dec) | +14.87% |
C000104936 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +6.2% | −1.7% | — | — | — | — | — | — | — | — | — | — |
| 2024 | +2.1% | +4.4% | +1.6% | −5.5% | +2.3% | +3.0% | +3.2% | +4.8% | −2.0% | −4.7% | +1.4% | −7.8% |
| 2023 | +1.0% | −4.9% | +1.7% | +3.8% | −2.6% | +3.1% | 0.0% | −1.8% | −4.1% | −4.3% | +6.1% | +7.1% |
| 2022 | −13.0% | −0.6% | +4.9% | −9.1% | −1.3% | −0.4% | +6.0% | −3.3% | −4.4% | +8.2% | +4.3% | −2.9% |
| 2021 | +2.0% | −1.8% | −1.3% | +4.9% | −1.3% | +6.4% | +1.8% | +4.5% | −5.1% | +3.8% | −5.1% | +2.9% |
| 2020 | −2.6% | −4.7% | −7.1% | +14.1% | +7.7% | +0.4% | +3.4% | +1.6% | +1.2% | −1.4% | +9.1% | +3.9% |
| 2019 | — | — | — | — | — | — | — | — | −3.5% | +6.6% | +8.6% | +2.8% |
C000104936 Risk
Risk measures from monthly returns over Mar 2022 – Feb 2025.
- 3-year volatility (annualised): 15.29%
- 3-year Sharpe ratio: -0.05 (vs 4.5% risk-free rate)
- Best month: +8.15% (Oct 2022)
- Worst month: −9.07% (Apr 2022)
C000104936 Fund Flows
Monthly money in and out of Health Sciences Fund, from SEC Form N-PORT.
- 12-month net flow: −$135.4M
- 12-month gross sales (incl. reinvestments): $60.8M
- Sales ÷ redemptions: 0.31×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Feb 2025 | $9K | $93.5M | −$93.5M |
| Jan 2025 | $272K | $35.2M | −$34.9M |
| Dec 2024 | $47.1M | $709K | $46.3M |
| Nov 2024 | $5.5M | $332K | $5.2M |
| Oct 2024 | $452K | $46K | $406K |
| Sep 2024 | $1.4M | $2.4M | −$1.0M |
| Aug 2024 | $26K | $9.9M | −$9.9M |
| Jul 2024 | $83K | $34.9M | −$34.8M |
| Jun 2024 | $548K | $16.2M | −$15.7M |
| May 2024 | $1.5M | $2.7M | −$1.2M |
| Apr 2024 | $2.8M | $191K | $2.6M |
| Mar 2024 | $1.2M | $86K | $1.1M |
C000104936 Assets Under Management
Net assets of Health Sciences Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-02-28 | $94.53M |
| 2024-11-30 | $227.11M |
| 2024-08-31 | $234.83M |
| 2024-05-31 | $268.14M |
| 2024-02-29 | $270.81M |
| 2023-11-30 | $255.38M |
| 2023-08-31 | $265.39M |
| 2023-05-31 | $304.02M |
| 2023-02-28 | $299.92M |
| 2022-11-30 | $324.33M |
| 2022-08-31 | $316.92M |
| 2022-05-31 | $334.11M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.